SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-027259
Filing Date
2023-05-30
Accepted
2023-05-30 16:39:48
Documents
12
Period of Report
2023-05-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K brhc20053683_8k.htm   iXBRL 8-K 32696
  Complete submission text file 0001140361-23-027259.txt   173220

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA angn-20230530.xsd EX-101.SCH 3859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE angn-20230530_lab.xml EX-101.LAB 23290
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE angn-20230530_pre.xml EX-101.PRE 16548
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc20053683_8k_htm.xml XML 4188
Mailing Address 7-57 WELLS AVENUE NEWTON MA 02459
Business Address 7-57 WELLS AVENUE NEWTON MA 02459 (857) 336-4001
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 23977111
SIC: 2834 Pharmaceutical Preparations